| P50 | author | Roberto Farina Almeida | Q82945699 |
| | Gisele Hansel | Q83677349 |
| | Daniel Diniz Comasseto | Q87034879 |
| P2093 | author name string | Eduardo R Zimmer | |
| | Diogo Onofre Souza | |
| | Samanta Oliveira Loureiro | |
| | Denise Barbosa Ramos | |
| | Marcelo Ganzella | |
| P2860 | cites work | 50 years of hurdles and hope in anxiolytic drug discovery | Q28297569 |
| | Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 |
| | Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. | Q31029356 |
| | Caffeine facilitation of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) through activation protein kinase C pathway: an interaction with presynaptic adenosine A1 receptors | Q48234824 |
| | A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. | Q48658263 |
| | A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo. | Q48703688 |
| | Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. | Q50955863 |
| | Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing. | Q51007174 |
| | Acute treatments with GMP produce antidepressant-like effects in mice. | Q53908936 |
| | Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition. | Q54581993 |
| | Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia | Q73372515 |
| | Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice. | Q33767200 |
| | Glutamate as a neurotransmitter in the healthy brain | Q34048502 |
| | The guanosine-adenosine interaction exists in vivo | Q34125107 |
| | The rise of a new GABA pharmacology | Q34146975 |
| | Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines | Q34246061 |
| | Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in Zebrafish. | Q34628537 |
| | The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review | Q35071470 |
| | The potential therapeutic effect of guanosine after cortical focal ischemia in rats. | Q35109170 |
| | Disturbance of the glutamatergic system in mood disorders | Q35149888 |
| | Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype. | Q35675947 |
| | Effects of 3 weeks GMP oral administration on glutamatergic parameters in mice neocortex. | Q35777621 |
| | Therapeutic options: Addressing the current dilemma. | Q36490697 |
| | Extracellular guanosine regulates extracellular adenosine levels | Q36699593 |
| | Proposal of a guanine-based purinergic system in the mammalian central nervous system. | Q36947502 |
| | Glutamate, glutamate receptors, and downstream signaling pathways | Q37249255 |
| | Purinergic signaling and energy homeostasis in psychiatric disorders | Q37284060 |
| | Adenosine and related drugs in brain diseases: present and future in clinical trials | Q37852724 |
| | The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects | Q37852727 |
| | Purinergic signalling: from normal behaviour to pathological brain function | Q37930074 |
| | Glutamate-based anxiolytic ligands in clinical trials | Q38110306 |
| | Novel glutamatergic drugs for the treatment of mood disorders | Q38131480 |
| | Gliopreventive effects of guanosine against glucose deprivation in vitro | Q39126996 |
| | Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway. | Q39334402 |
| | Guanosine prevents thermal hyperalgesia in a rat model of peripheral mononeuropathy | Q39949080 |
| | Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety | Q40649047 |
| | Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides | Q42011931 |
| | Two distinct pathways for metabolism of theophylline and caffeine are coexpressed in Pseudomonas putida CBB5. | Q42110137 |
| | Cell-type-specific recruitment of amygdala interneurons to hippocampal theta rhythm and noxious stimuli in vivo | Q42186938 |
| | Tissue distribution and metabolism of guanosine in rats following intraperitoneal injection | Q42504490 |
| | Systemic administration of GMP induces anxiolytic-like behavior in rats. | Q43010610 |
| | Effects of depressive-like behavior of rats on brain glutamate uptake. | Q43092657 |
| | Activation of glutamate uptake by guanosine in primary astrocyte cultures. | Q43558663 |
| | Effect of orally administered guanosine on seizures and death induced by glutamatergic agents. | Q43726002 |
| | Effects of adenosine receptor agonists and antagonists on pentylenetetrazole-induced amnesia | Q43800968 |
| | Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition | Q44014265 |
| | Oral administration of guanosine impairs inhibitory avoidance performance in rats and mice | Q44780304 |
| | Anticonvulsant effect of GMP depends on its conversion to guanosine. | Q44814268 |
| | Adenosine A1 receptors modulate the anxiolytic-like effect of ethanol in the elevated plus-maze in mice. | Q45056184 |
| | Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus. | Q46490137 |
| | In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine. | Q46631297 |
| | Neuroprotective effects of guanosine administration on behavioral, brain activity, neurochemical and redox parameters in a rat model of chronic hepatic encephalopathy. | Q46899015 |
| | Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways. | Q47978385 |
| P433 | issue | 1 | |
| P921 | main subject | neurotransmitter | Q162657 |
| P304 | page(s) | 423-436 | |
| P577 | publication date | 2016-01-07 | |
| P1433 | published in | Molecular Neurobiology | Q15716645 |
| P1476 | title | Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems | |
| P478 | volume | 54 | |